1-20 of 91
Keywords: Myelodysplastic syndrome
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2024) 147 (2): 122–132.
Published Online: 08 December 2023
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Acute myeloid leukemia Classification Myelodysplastic syndrome Consensus classification of acute myeloid leukemia (AML) began in the 1970s with the French-American...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2024) 147 (2): 175–185.
Published Online: 05 December 2023
... genomic integrity and preventing the development of cancer. TP53 mutations are frequently observed in AML (∼10% of patients) and are associated with aggressive disease behavior, resistance to therapy, and poor prognosis. Summary: Recent changes in classification of TP53 -mutated myelodysplastic syndrome...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2024) 147 (4): 457–464.
Published Online: 21 November 2023
... therapies for acute myeloid leukemia (AML) have not yet been described. Methods: Through retrospective review of 19,432 patients diagnosed with acute/chronic leukemia or myelodysplastic syndromes/myeloproliferative neoplasms (MDS+/−MPN) over 28 years, we calculated the incidence of SS in the setting...
Journal Articles
Acta Haematol (2023) 146 (3): 230–239.
Published Online: 05 June 2023
... Castilla-Llorente; Nathalie Contentin; Anne Huynh; Ibrahim Yakoub-Agha; Claude-Eric Bulabois; Marie-Thérèse Rubio; Maud D’Aveni Introduction: Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remains the best curative option for high-risk myelodysplastic syndrome (MDS) and acute myeloid...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2021) 144 (6): 649–659.
Published Online: 07 July 2021
... with hypomethylating agents (HMAs). Methods: We performed next-generation sequencing on bone marrow aspiration samples of 59 patients diagnosed with acute myeloid leukemia (AML), myelodysplastic syndrome with excess blasts-2, or chronic myelomonocytic leukemia and treated with decitabine or azacitidine as a frontline...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2021) 144 (3): 332–336.
Published Online: 02 October 2020
...Federica Pilo; Giovanni Caocci; Giannalisa Mele; Giorgio La Nasa Low-risk patients with myelodysplastic syndromes (MDS) are inclined to long-term accumulation of iron in the organs due mostly to red blood cell transfusion and ineffective erythropoiesis. The effect of free toxic iron species...
Journal Articles
Acta Haematol (2021) 144 (2): 132–145.
Published Online: 11 May 2020
... to in the content or advertisements. Acute leukemia Chronic leukemia Myelodysplastic syndrome COVID-19 The novel betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initially described in Wuhan, China, in December 2019. Since then, more than 2.5 million people worldwide...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2020) 143 (2): 140–145.
Published Online: 22 July 2019
...Akihiro Takeuchi; Osamu Imataki; Hiroyuki Kubo; Akihiro Kondo; Kayoko Seo; Makiko Uemura; Genji Yamaoka; Koji Murao; Akihiro Takeuchi Background: Myelodysplastic syndromes (MDS) and idiopathic cytopenia of undetermined significance (ICUS) are heterogeneous hematological disorders characterized...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2017) 138 (3): 168–174.
Published Online: 19 October 2017
... for the treatment of myelodysplastic syndrome (MDS) is 20 mg/m 2 /day for 5 consecutive days with a relatively high incidence of treatment-related morbidities and costs. In this study, a retrospective and multicenter analysis was performed to explore the very-low-dose decitabine schedule for the treatment...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2017) 138 (2): 119–128.
Published Online: 02 September 2017
...Yali Du; Zhangbiao Long; Miao Chen; Bing Han; Bo Hou; Feng Feng Background: This study focuses on the iron overload (IOL) of patients with transfused aplastic anemia (AA) or a low/intermediate-1 risk of myelodysplastic syndrome (MDS). Methods: Ninety-two AA or MDS patients with IOL were...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2017) 138 (1): 39–43.
Published Online: 20 July 2017
... chemotherapy and their relationship with markers of immunoparalysis in leukemia patients. In 6 patients with acute myeloid leukemia or myelodysplastic syndrome and 12 healthy subjects, DAMPs, cytokines, and markers of immunoparalysis were determined before and during the first week after chemotherapy...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2016) 136 (2): 108–117.
Published Online: 01 February 2016
...Ofir Wolach; Richard Stone Autoimmune and inflammatory conditions (AICs) are encountered in up to 25% of patients with myelodysplastic syndromes (MDS). A wide range of AICs have been reported in association with MDS and can range from limited clinical manifestations to systemic diseases affecting...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2016) 135 (2): 94–100.
Published Online: 28 October 2015
...Dolors Costa; Concha Muñoz; Ana Carrió; Amparo Arias; Cándida Gómez; Francesc Solé; Blanca Espinet; Gemma Azaceta; María J. Calasanz; Meritxell Nomdedeu; Xavier Calvo; Elias Campo; Benet Nomdedeu Recurrent translocations are uncommon in myelodysplastic syndromes (MDS). Three new recurrent...
Journal Articles